Quick Summary:
In the rapidly transforming market landscape, strategic business decisions need to be grounded in reliable, data-intensive insights. This need highlights the immense value contained in our comprehensive market research report on Global Technology Spending on Revenue Cycle Management.
The report estimates the global market at $41 billion in 2022 and predicts significant growth to $63.1 billion by 2030. With in-depth analysis of key segments, such as Integrated and Standalone, the report offers a detailed exploration of projected market trajectories. Furthermore, the geographic analysis covers major economies such as the U.S and China, along with emerging markets, providing a global perspective.
In addition to providing extensive analysis of current market conditions, our report details the landscape of major competitors, offering a comprehensive view of the competitive intensity in this market. The report further provides unrivaled access to digital archives, bespoke updates, and complimentary amendments for one year for smooth decision-making. Make your strategic decisions smarter and faster with this indispensable business tool.
Global Technology Spending on Revenue Cycle Management Market to Reach $63.1 Billion by 2030
The global market for Technology Spending on Revenue Cycle Management estimated at US$41 Billion in the year 2022, is projected to reach a revised size of US$63.1 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2022-2030. Integrated, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$48.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Standalone segment is readjusted to a revised 4.7% CAGR for the next 8-year period.The U.S. Market is Estimated at $12.3 Billion, While China is Forecast to Grow at 5.1% CAGR
The Technology Spending on Revenue Cycle Management market in the U.S. is estimated at US$12.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$11 Billion by the year 2030 trailing a CAGR of 5.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.4% and 4.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.Select Competitors (Total 46 Featured) -
- 3M Health Information Systems
- Allscripts Healthcare Solutions, Inc.
- Cerner Corporation
- Computer Programs and Systems, Inc. (CPSI)
- GE Healthcare
- McKesson Corporation
- Optum, Inc.
- Vizient Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Technology Spending on Revenue Cycle Management?
What is the growth rate of the Global Market for Technology Spending on Revenue Cycle Management?
What is the forecasted size of the Global Market for Technology Spending on Revenue Cycle Management?
Who are the key companies in the Global Market for Technology Spending on Revenue Cycle Management?
Report Attribute | Details |
---|---|
No. of Pages | 246 |
Published | October 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 41 Billion |
Forecasted Market Value ( USD | $ 63.1 Billion |
Compound Annual Growth Rate | 5.5% |
Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- 3M Health Information Systems
- Allscripts Healthcare Solutions, Inc.
- Cerner Corporation
- Computer Programs and Systems, Inc. (CPSI)
- GE Healthcare
- McKesson Corporation
- Optum, Inc.
- Vizient Inc.